OpenBilldrug price receipt

NADAC week of 2026-10-14

TELMISARTAN-AMLODIPINE 80-5 MG

For 30 tablets

Pharmacies pay

$86.11 filed

30 × $2.87025 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$70.32 filed

30 × $2.34385 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.82× estimated

Medicare paid 18% less than pharmacies pay.

Part D averages every strength and form sold under “Telmisartan-Amlodipine” / “Telmisartan/Amlodipine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$104.03 estimated

$86.11 + $12.92 (15%) + $5.00 fee per fill = $104.03

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TELMISARTAN-AMLODIPINE 80-5 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as telmisartan and amlodipine.

FDA gives its dosage form as tablet and its route as oral.

The labeler, the company named on the label, is Mylan Pharmaceuticals Inc.

FDA lists it under 3 Established Pharmacologic Classes: Angiotensin 2 Receptor Blocker, Calcium Channel Blocker and Dihydropyridine Calcium Channel Blocker.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00378-1077-93.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $86.11 for 30 tablets (30 × $2.87025 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name telmisartan and amlodipine with TELMISARTAN-AMLODIPINE 80-5 MG.

ProductPharmacies pay per unitMedicare per unit
TELMISARTAN-AMLODIPINE 40-5 MG
generic · tablet
$3.19076 per EA filed
eff. 2026-09-23
$2.34385 per EA filed
Part D 2024 average
TELMISARTAN-AMLODIPINE 40-10
generic · tablet
$2.87974 per EA filed
eff. 2026-09-23
$2.34385 per EA filed
Part D 2024 average
TELMISARTAN-AMLODIPINE 80-5 MG this page
generic · tablet
$2.87025 per EA filed
eff. 2026-09-23
$2.34385 per EA filed
Part D 2024 average
TELMISARTAN-AMLODIPINE 80-10
generic · tablet
$2.93583 per EA filed
eff. 2026-09-23
$2.34385 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $2.87025 per EA filed.

Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 52 have a higher middle NADAC price and 55 a lower one. The one in the middle is CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, at $1.07781 per EA filed (eff. 2026-09-23).

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 28 have a higher middle NADAC price and 79 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG, at $0.99481 per EA filed (eff. 2026-09-23).

Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 25 have a higher middle NADAC price and 42 a lower one. The one in the middle is NICARDIPINE 20 MG CAPSULE, at $1.12012 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $70.32 for 30 tablets, at an average of $2.34385 per EA in 2024 (2024-01-01 to 2024-12-31) for “Telmisartan-Amlodipine” and “Telmisartan/Amlodipine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 24,841 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for TELMISARTAN-AMLODIPINE 80-5 MG labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Telmisartan-Amlodipine / Telmisartan/Amlodipine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.